GlaxoSmithKline LLC recalls ANORO ELLIPTA (umeclidinium and vilanterol inhalation powder) 62.5 mcg/25mcg. 1 inhaler contains 30 doses (60 blisters
Recalled January 3, 2024 · FDA recall D-0160-2024 · GlaxoSmithKline
Hazard
Failed Release Testing: Coarse Particle Mass for umeclidinium Out of Specification · FDA Class III
Units
67,508 inhalers
Sold at
Distributed Nationwide in the USA and Puerto Rico.
Description
Failed Release Testing: Coarse Particle Mass for umeclidinium Out of Specification
Product
ANORO ELLIPTA (umeclidinium and vilanterol inhalation powder) 62.5 mcg/25mcg. 1 inhaler contains 30 doses (60 blisters total), Rx Only, Manufactured by GlaxoSmithKline Durham, NC 27701. NDC 0173-0869-10
Manufacturer(s)
GlaxoSmithKline LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →